
|Articles|August 7, 2015
FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
A look back at the top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/fda-warning-on" target="_blank">View the story "FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
3
G-CSF is a Potential Alternative in Treatment of Hot Flashes in Postmenopausal Women
4
CHEST 2025: Advancing Respiratory Virus Vaccines and Improving Uptake Among High-Risk Populations
5
















































































































































































































